Contrast-enhanced ultrasound no aid for metastasis detection

Contrast-enhanced ultrasound no aid for metastasis detection

(HealthDay)—Contrast-enhanced laparoscopic ultrasonography (CE-LUS) does not appear to increase the detection rate of liver metastasis during robotic-assisted surgery for primary colorectal cancer (CRC), according to a study published online Nov. 13 in the Journal of Clinical Ultrasound.

Signe Bremholm Ellebæk, M.D., from Odense University Hospital in Denmark, and colleagues assessed the potential clinical value of CE-LUS as a for during robotic-assisted surgery for primary CRC among 50 consecutive patients.

The researchers found that patients were equally distributed between stage I, II, and III classification. CE-LUS did not detect any , as was confirmed by follow-up using contrast-enhanced computed tomography imaging at three and 12 months postoperatively. CE-LUS was easy to perform and no complications were reported.

"The use of CE-LUS as a screening modality for detection of liver metastasis cannot be recommended based on this study, but larger controlled studies on high-risk patients seem relevant," the authors write.


Explore further

Bariatric surgery alters liver fatty acid metabolism

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Contrast-enhanced ultrasound no aid for metastasis detection (2017, December 15) retrieved 19 July 2019 from https://medicalxpress.com/news/2017-12-contrast-enhanced-ultrasound-aid-metastasis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more